Table 1. The Effect of Smoking onmeibomian gland dysfunction (MGD) Parameters.
Parameters | Smokers | Non-smokers |
---|---|---|
Both sexes | ||
OSDI | 36.15±0.93 | 35.85±0.39 |
TBUT | 4.00±0.14 | 3.96±0.05 |
CFS | 1.70±0.15 | 1.84±0.06 |
SIT | 6.29±0.30 | 6.92±0.15 |
Lid margin abnormality score** | 0.78±0.04 | 0.60±0.02 |
Meibomian gland expressibility score | 1.26±0.05 | 1.37±0.02 |
Meibum Score** | 1.03±0.05 | 0.82±0.02 |
Male | ||
OSDI | 35.77±0.98 | 34.62±0.70 |
TBUT | 4.10±0.16 | 4.05±0.11 |
CFS | 1.57±0.15 | 1.78±0.11 |
SIT | 6.43±0.32 | 7.15±0.28 |
Lid margin abnormality score** | 0.80±0.04 | 0.62±0.03 |
Meibomian gland expressibility score | 1.21±0.06 | 1.32±0.04 |
Meibum Score** | 1.05±0.06 | 0.81±0.04 |
Data shown as mean ± SE;
** P<0.01
OSDI: Ocular Surface Disease Index; TBUT: tear film breakup time; CFS: corneal fluorescein staining; SIT: Schirmer I test.